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lation of the AQP-2 gene leads to the decrease in urinary con-Role of aquaporin-2 gene expression in hyponatremic rats with
centrating ability in the experimental SIADH rats, sufferingchronic vasopressin-induced antidiuresis.
from hypervolemic state, compared with the normonatremicBackground. In a state of chronic arginine vasopressin (AVP)
rats receiving AVP. Either hypervolemia or hypotonicity mayexcess, the action of antidiuresis has been attenuated, resulting
diminish the post-receptor signaling of AVP in renal collectingin some water diuresis. This state has been termed an “AVP
duct cells, under the chronic AVP excess state found in SIADH.escape” phenomenon. The present study was designed to deter-
mine what mechanisms underlie this attenuation in renal con-
centrating ability, which is found in chronic AVP excess, both
in the presence and absence of volume expansion.
Persistent elevation of plasma arginine vasopressinMethods. Two groups of experimental rats were established.
(AVP), despite hypoosmolality, is found in syndrome ofOne group received solid chow with water ad libitum. The sec-
ond group received chow, which was offered as a liquid diet. inappropriate secretion of antidiuretic hormone (SIADH)
Both groups received subcutaneous administration of 1-deamino- [1, 2]. AVP-dependent antidiuresis leads to impaired
8-d-arginine vasopressin (dDAVP) at 5 ng/h for the entire obser- water excretion and hyponatremia [3, 4]. In the chronicvation period of one week. Over the course of the observation
AVP excess condition, however, antidiuresis is attenuated,period, tissue levels of aquaporin-2 (AQP-2) mRNA and pro-
resulting in water diuresis to some extent. These altera-tein were measured. Levels of AVP V2 receptor were monitored,
both by measuring mRNA levels and by ligand-binding studies tions set water balance to a new steady state, and there-
using [3H]AVP. Tissue levels of cAMP also were determined. fore, hyponatremia persists at a reset level. This has been
Results. Experimental rats with the syndrome of inappropri- called the “AVP escape” phenomenon from antidiuresis.ate secretion of antidiuretic hormone (SIADH) had severe hypo-
The mechanisms whereby water diuresis is produced havenatremia below 120 mmol/L, and impaired urinary concentrating
been investigated extensively [5–8]. Recently, severalability, during the seven-day observation period. In contrast,
the dDAVP-excess rats, given solid chow, maintained maxi- studies have demonstrated that both AVP-independent
mally concentrated urine and normal levels of serum sodium. down-regulation of AVP V2 receptor function and aqua-
The down-regulation of AVP V2 receptor function was compa- porin-2 (AQP-2) expression, at least in part, participaterable in the two groups. The maximal binding capacity (Bmax) in the initiation of escape from AVP-induced antidiure-fell to the nadir on day 2 and was thereafter suppressed at
sis, in rats with experimental SIADH [9–11]. Further studyapproximately 60% of control rats during the experiment. Up-
regulation of AQP-2 mRNA expression was found, but this suggested that some factors, related to extracellular fluid
up-regulation was significantly less in the SIADH rats com- expansion, could regulate renal AQP-2 expression [12].
pared with the dDAVP-excess rats (153.5  29.8% vs. 323.7  In response to AVP, concentrated urine is produced23.8% on day 7, P  0.05). This differential response between
by water reabsorption across the renal collecting ductthese two groups was affirmed by measured differences in
[13, 14]. Sasaki et al recently cloned a complementaryAQP-2 protein levels, both in tissue and in urinary excretion.
Conclusions. These results indicate that the attenuated regu- DNA of the apical collecting duct water channel, AQP-2,
from rat and human kidneys [15, 16]. AVP is crucially
involved in both short-term and long-term regulations
1 See Editorial by Verbalis, p. 1608. of AQP-2 in collecting duct cells. Specifically, endoge-
nous and exogenous AVP stimulates cellular traffickingKey words: gene expression, arginine vasopressin, SIADH, water di-
uresis, AVP escape phenomenon, extracellular fluid. of AQP-2 from cytoplasmic vesicles to apical plasma mem-
branes, and it also increases the expression of AQP-2Received for publication August 17, 2000
mRNA in the collecting duct cells [15, 17–25]. A cAMP-and in revised form April 3, 2001
Accepted for publication April 21, 2001 responsive element is located in the 224 bp of 5-flanking
region of the AQP-2 gene [26, 27]. Because AVP is well 2001 by the International Society of Nephrology
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known to increase cAMP levels in renal collecting duct planted subcutaneously along the back under ether
anesthesia. dDAVP was infused at a rate of 5 ng/h. Aftercells [13, 14], it is highly likely that AVP regulates the
transcriptional rates of the AQP-2 gene [27, 28]. The the recovery, the animals were placed in cages with ac-
cess to the modified liquid diet, but without water bottles,enhanced expression of AQP-2 mRNA is abolished by
the presence of an AVP V2 receptor antagonist [17, 22, for an additional seven days. The other group of rats
was prepared similarly, but they were given commercial29, 30] or an acute water load that cause a reduction in
plasma AVP levels [31]. Recent studies have shown the rat pelleted chow, instead of the liquid diet, with free
access to water during the seven-day observation periodup-regulation of AQP-2 gene expression in kidney under
certain specific conditions such as dehydration, SIADH, (dDAVP-excess rats). In addition, control groups of rats
were given 0.15 mol/L NaCl for the vehicle of dDAVPliver cirrhosis with ascites, and congestive heart failure
[21, 29–33]. Such findings mean the activation of long- by osmotic minipump, and the liquid diet or the pelleted
chow orally.term up-regulation of AQP-2. Sustained exposure to the
low-grade excess AVP plays a crucial role in the impair- The four groups of rats were placed individually into
metabolic cages and observed for seven days. Before thement in water excretion [34, 35].
The present study examined the mechanisms involved implantation of osmotic minipumps, 1 mL blood sam-
ples were collected from tail blood vessels and samplesin attenuation of the renal concentrating ability in a
chronic AVP excess condition, in the presence or ab- were collected on days 2, 4, and 6 after implantation.
Serum sodium (SNa) levels were determined; 24-hoursence of volume expansion. Specifically, the inverse regu-
lation of AQP-2 gene expression and AVP V2 receptor urine collections were made on days 0, 2, 4, and 6 after
implantation for measures of urine volume, urinary os-function has been determined. We confirmed the finding
of an impairment in the maximal expression of AQP-2 molality (UOsm), and urinary excretion of AQP-2. In addi-
tion, body weight and water intake were measured. UOsmgene in the experimental SIADH rats by a model that
is somewhat different from that described in the studies was measured by freezing-point depression (model 3W2;
Advanced Instruments, Needham Heights, MA, USA).of Ecelbarger et al and Murase et al [9, 12]. However,
in the present study, the down-regulation of AVP V2 Serum Na was measured by flame photometer (model
736; Hitachi, Tokyo, Japan).receptor function could not be demonstrated, indepen-
dent of AVP. Finally, our studies indicate that either Similarly, another series of two groups of rats (experi-
mental SIADH rats and dDAVP-excess rats) were pre-hypervolemia or hypotonicity may diminish the post-
receptor signaling of AVP under chronic AVP excess. pared and then killed by decapitation. Both kidneys were
removed to study the expressions of AQP-2 mRNA and
protein, and AVP V2 receptor mRNA, [3H]AVP recep-METHODS
tor binding and tissue cAMP contents. The group of
SIADH model rats experimental SIADH rats was killed sequentially, in
groups of four, at specific time points: 0 hours, 3 hours,The experimental procedure was similar to that de-
scribed in our previous studies [29, 36], modified from the 12 hours, 2 days, 4 days, and 7 days after the implantation.
The group of rats receiving dDAVP with free access tomethod of Verbalis and Drutarosky [5]. Male Sprague-
Dawley rats weighing 200 to 220 g were used. They were water, which were called dDAVP-excess rats, was killed
sequentially, in groups of four, at specific time points:housed individually in cages at room temperature of
21C to 23C with the light on from 8 a.m. to 8 p.m., and 0 hours, 3 hours, 2 days, and 7 days after the implantation.
were acclimated for four days to a commercial, nutri-
Northern blot analysistionally balanced liquid diet (Japan Clea, Tokyo, Japan).
The formula of this diet supplies 1.0 kcal/mL, consisting This study was performed as described previously,
with some modification [15, 29]. Total cellular RNA fromof 56% carbohydrate, 16% protein, and 17% fat, along
with 48 mmol/day sodium, 12.1 g/day glucose, vitamins, whole kidneys was extracted by the acid guanidium thio-
cyanate-phenol-chloroform method [37]. Total RNAand trace elements. The liquid diet was supplied to the
animals at 60 mL/day in 100 mL glass liquid feeding (20 g) was denatured with formamide and formalde-
hyde at 65C for 15 minutes and then electrophoresedtubes (Liquid Diet Feeding Tube; Bio-Serv, Frenchtown,
NJ, USA). After an osmotic minipump was implanted on a 1% agarose-2.2 mol/L formaldehyde gel, blotting
onto nylon membrane filters (Hybond-N; Amersham(Alza model 2002, Palo Alto, CA, USA), the liquid diet
was changed to that containing 14% dextrose, in which Int., Buckinghamshire, UK). The cDNA probes for rat
AQP-2 and -actin were labeled with DIG-11-UTP bythe caloric density was 1.9 kcal/mL, supplied at 50 mL/
day in 100 mL glass liquid feeding tubes. Osmotic mini- random primed labeling method (DIG DNA labeling
kit; Roche, Tokyo, Japan). The filters were hybridizedpumps, containing 1-deamino-8-d-arginine vasopressin
(dDAVP; Kyowa-Hakko, Tokyo, Japan), dissolved in 0.15 at 42C for at least 12 hours with the probes. After hy-
bridization, the filters were washed twice in 2 standardmol/L NaCl at a concentration of 10 g/mL, were im-
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sodium citrate (SSC) and 0.1% sodium dodecyl sulfate (BSA)]; 200L of the binding buffer were added into the
tubes in duplicate, containing 2  10	9 mol/L [3H]AVP(SDS) for 20 minutes at room temperature and then
washed three times with 0.2  SSC and 0.1% SDS at (specific activity, 67.6 Ci/mmol; New England Nuclear,
Boston, MA, USA) in the absence or presence of cold42C. The filters were incubated by CSPD (Tropix, Inc.,
Bedford, MA, USA) and were exposed to Kodak AVP at nine specific concentrations, ranging from 1 
10	9 to 1 10	6 mol/L. The binding reaction was initiatedX-OMAT film (Eastman Kodak, Rochester, NY, USA)
for four hours at 37C. The films were analyzed by densi- by the addition of approximately 100 g of membrane
fraction. Samples were incubated at 4C for 60 minutes.tometry (CS-9000; Shimadzu, Kyoto, Japan) for quanti-
tative comparisons. Sample comparisons were made on After the incubation, 3 mL of the ice-cold binding buffer
were added to each sample. They were then filteredspecific density ratios of AQP-2 mRNA versus -actin
mRNA for each sample. Finally, individual sample ratios through glass microfiber filters (Whatman 2.4-cm GF/C;
Whatman, Maidstone, UK). The filters were rinsed threewere expressed as a percentage increase compared with
the density of control. times with 3 mL of ice-cold binding buffer. They were
put into counting vials with 10 mL of scintillation solu-
Western blot analysis tion. The radioactivity was counted with a liquid scintilla-
tion counter (model LSC-671; Aloka, Tokyo, Japan).The expression of AQP-2 protein in the kidney me-
dulla was determined by Western blot analysis as de- Membrane fraction protein was measured by Bio-Rad
protein assay kit (Bio-Rad, Tokyo, Japan).scribed previously [29, 31]. Membranes were prepared
from rat kidney medulla by homogenization in a Potter-
Semiquantitative multiprimer RT-PCRElvehjem apparatus. After homogenization in 10 vol-
umes of 0.32 mol/L sucrose, 5 mmol/L Tris-HCl, 2 mmol/L Total RNA was isolated from whole kidney in the
same manner described in the method of Northern blotethylenediaminetetraacetic acid (EDTA), 0.1 mmol/L
phenylmethylsulphonyl fluoride (PMSF), two centrifu- analysis. Reverse transcription was performed using a
cDNA synthesis kit (SuperScript Preamplification Sys-gations (1000 g, 10 min) were performed. Finally, super-
natants were centrifuged at 250,000  g for 30 minutes, tem for First Strand cDNA Synthesis; GIBCO BRL, Life
Technology, Rockville, MD, USA). It was carried out inand the pellets were suspended in the same buffer (mem-
brane fraction). The samples were solubilized in a sample a 20 L reaction volume containing 5 g total RNA,
6 L of buffer, 1 L of RNase inhibitor, 1 L of deoxy-loading buffer; 3% SDS, 65 mmol/L Tris-HCl, 10% glyc-
erol, 5% 2-mercaptoethanol, and heated at 70C for five nucleotide mixture, 5 L of random primer, and 1 L
(200 U) of SuperScriptRT. Reaction tubes were incu-minutes. They were separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) using bated at 42C for 50 minutes, and the reaction was
stopped by heating at 70C for 15 minutes. Then, reac-10% polyacrylamide gels and then transferred to polyvi-
nyl membranes (Immobilon; Millipore Corp., Bedford, tion tubes were placed on ice until the addition of poly-
merase chain reaction (PCR) reagents. PCR was carriedMA, USA). The blots were incubated with an antiserum
(1:100 dilution) against 15 carboxyl-terminal synthetic out using 1 L cDNA stock solution in the presence
of 0.01 U/L r-Taq enzyme (Takara, Otsu, Japan), 0.2peptides of rat AQP-2 [Tyr0-aquaporin-2 (V257-A271)].
After rinsing, the blots were immersed with a 1:10,000 mol/L gene-specific primer, 200 mol/L dNTPs, 10
mmol/L Tris-HCl, 1.5 mmol/L MgCl2, 50 mmol/L KCl,dilution of goat anti-rabbit horseradish peroxidase-con-
jugated antibodies. Finally, blots were incubated with and 0.1% Triton X-100, with 24 cycles (57C for 30 sec,
72C for 5 min, 95C for 60 sec), starting at 95C for onethe enhanced chemiluminescence (ECL) substrate and
exposed to Hyperfilm ECL to visualize the immunoreac- minute and finishing at 72C for five minutes. The gene-
specific primers of AQP-2 and -actin were preparedtive bands.
according to the study of Yasui et al [39]. The primers
AVP receptor binding of AQP-2 were 5-AGTGCTGGCTGAGTTCTTGG-3
(antisense) and 5-GCTGTGGCGTTGTTGTGGAG-3The experimental procedure was a modification of
the method of Jard et al [38]. Renal medullary tissues (sense). Those of AVP V2 receptors were 5-CCTCCTA
CATGATCCTGGCCATGAG-3 (antisense) and 5-TGCfrom two kidneys were homogenized in a Potter-Elveh-
jen apparatus in 10 volumes of homogenized solution ACCAGGAAGAAGGGTGCCCAGCA-3 (sense), and
those of -actin were 5-TGAACCCTAAGGCCAAC(0.32 mol/L sucrose, 5 mmol/L Tris-HCl, 2 mmol/L EDTA,
0.1 mmol/L PMSF). After the homogenization, the sam- CGT-3(antisense) and 5-GCTAGGAGCCAGGGCA
GTA-3 (sense). The product sizes of AQP-2, V2 recep-ples were centrifuged twice at 1000  g for 10 minutes at
4C. The supernatants were then centrifuged at 15,000 g tor, and -actin were 344, 523, and 635 bp, respectively.
Twenty microliters of the PCR solution were separatedfor 30 minutes at 4C, and the pellets were suspended
in the ice-cold binding buffer [50 mmol/L Tris-HCI, on a 2% agarose gel and stained with ethidium bromide.
Each reverse transcription-polymerase change reactionpH 7.4, 5 mmol/L MgCl2, 1 mg/mL bovine serum albumin
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Table 1. Changes in body weight, urine volume, UOsm, serum Na levels and water intake in the
experimental SIADH and the dDAVP-excess rats
Day
Variable 0 2 4 6
Body weight g
Control rats (A)/liquid diet 205.55.2 210.55.3 207.01.3 206.32.0
SIADH rats 207.64.9 229.64.4 206.24.5 200.64.7
Control rats (B)/chow diet 206.14.4 217.03.6 226.02.6 241.63.4
dDAVP-excess rats 205.16.2 239.74.9b 259.06.8b 277.05.9b
Urine volume mL/day
Control rats (A)/liquid diet 28.51.6 27.00.6 26.01.0 34.42.6
SIADH rats 28.52.6 11.32.9b 16.73.4a 17.01.5b
Control rats (B)/chow diet 29.50.8 12.11.5b 13.10.6b 12.71.0b
dDAVP-excess rats 28.41.5 7.80.6b 7.80.6b 8.90.3b
UOsm mmol/kg
Control rats (A)/liquid diet 322.50.8 367.734.5 323.721.9 332.79.8
SIADH rats 343.50.7 1706.5307.1b 825.592.8b 832.384.6b
Control rats (B)/chow diet 328.70.8 1419.330.9b 1422.753.7b 1418.583.2b
dDAVP-excess rats 332.80.6 2674.5232.1b 3185.157.7b 3067.012.2b
Serum Na mmol/L
Control rats (A)/liquid diet 141.20.5 141.81.1 139.50.8 138.81.1
SIADH rats 140.70.8 119.31.9b 111.22.6b 114.31.5b
Control rats (B)/chow diet 140.20.7 139.60.8 140.40.5 139.50.5
dDAVP-excess rats 139.50.8 138.01.1 138.80.7 137.31.2
Water intakec mL/day
Control rats (A)/liquid diet 43.01.6 41.42.6 42.80.5 44.30.3
SIADH rats 34.62.7 29.33.1 29.73.8 31.73.2
Control rats (B)/chow diet 36.41.5 28.71.6 29.11.9 27.51.7
dDAVP-excess rats 34.41.4 25.71.0 16.01.5b 15.01.9b
Abbreviations are: SIADH, syndrome of inappropriate secretion of antidiuretic hormone; dDAVP, 1-damino-8-d-arginine vasopressin. Values are means SEM, N
 4.
a P  0.05.
b P  0.01 vs. the value on day 0.
c Water intake means the intake of liquid diet in the control rats (A) and SIADH rats.
Fig. 1. Changes in maximal binding capacity (Bmax) during the seven-
day observation period in the experimental SIADH rats and the dDAVP- Fig. 2. Densitometric analysis of expression of AVP V2 receptor
excess rats. Symbols are: () SIADH rats; () dDAVP-excess rats. mRNA, analyzed by RT-PCR, in kidneys of the experimental SIADH
Bmax is calculated from the Scatchard analysis of [3H]AVP binding to the rats () and the dDAVP-excess rats (). *P  0.05 and **P  0.01
membrane fractions of renal medulla. Values are means  SEM, N 
 3. vs. the control values. Values are means  SEM, N 
 4.
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Fig. 3. Northern blot analysis of expression of
rat AQP-2 mRNA in kidney of the experimen-
tal SIADH rats (A) and the dDAVP-excess
rats (B).
(RT-PCR) product was subjected to restriction-enzyme dilution curves of the urine samples were parallel to that
of the standard curve (data not shown).analysis to verify the specificity (data not shown). When
the reverse transcriptase was omitted from the RT reac-
Tissue cAMP measurementstion solution, no products appeared, confirming that the
Renal medullary tissues were dissected from the ex-products were produced from mRNA and not contami-
perimental SIADH rats and the dDAVP-excess rats atnating genomic DNA. All semiquantitative multiprimer
three hours and on days 2 and 7. The tissues were minced(SQM) RT-PCRs were made at least three times with
with 1 mL Krebs-Ringer buffered saline, pH 7.4; 100 Lthree different RNA preparations. All reaction solutions
of the tissue suspensions were incubated with 1 (except RNA and enzymes) in the SQM RT-PCR were
10	7 mol/L AVP or the vehicle at 37C for 10 minutespremixed to eliminate errors during pipetting. The Hi-
in the presence of 5  10	4 mol/L IBMX. Then, 0.2 mLLoDNA Marker (Abetec, Tokyo, Japan) was used on
of 0.1 N HCl was added [41]. The sample, in glass tubes,all agarose gels as a molecular weight marker.
was boiled for three minutes. After centrifuging the tubes
at 3000  g for 15 minutes at room temperature, theRadioimmunoassay of aquaporin-2
supernatants were decanted and 0.05 mL of 50 mmol/LUrinary AQP-2 immunoreactivity was measured by a
sodium acetate was added. Supernatants were stored atspecific radioimmunoassay using the antibody against
	20C until assay for cAMP. cAMP was measured bythe synthetic peptide [Tyr0-aquaporin-2 (V257-A271)]
radioimmunoassay using Yamasa cAMP kit (Choshi, Ja-corresponding to the 15-amino-acid sequence of the C
pan) [42]. The pellets, from the previous centrifugation,terminal of AQP-2, as described earlier [40]. The peptide
were dissolved in 0.2 mL of 0.1% SDS and kept at 4Cwas radioiodinated with 125Iodine (New England Nu-
until assay for protein. Protein was measured using Bio-
clear) by chloramine T. For the assay, urine samples
Rad protein assay kit.
were diluted into assay buffer in a final dilution of 1:2
to 1:32. 0.1 mL of the sample, 0.1 mL of the assay buffer Statistical analysis
(0.05 mol/L sodium phosphate, pH 7.4, 0.08 mol/L so- Values of body weight, urine volume, UOsm, SNa, cAMP,dium chloride, 0.01 mol/L EDTA, 0.5% BSA, 0.5% urinary excretion of AQP-2, maximal binding capacity
NP-40, and 0.01% sodium azide), and 0.1 mL of the (Bmax), ratio of the density of AQP-2 mRNA or AVP V2antibody (final dilution, 1:12,000) were incubated at 4C receptor mRNA to that of -actin mRNA, and density
for 48 hours, followed by the addition of 0.1 mL of of AQP-2 protein in immunoreactive bands were ana-
radiolabeled synthetic peptide (10,000 cpm), with further lyzed by the analysis of multiple variance (ANOVA) and
incubation at 4C for 48 hours. Bound and free quantities Student t test. A P value of less than 0.05 was considered
of radiolabeled ligand were separated by the double- significant.
antibody method. The minimal detectable quantity of
AQP-2 was 0.86 pmol/tube. An amount of AQP-2 equiv-
RESULTSalent to 6.9 pmol/tube caused 50% inhibition of binding
of the radiolabeled ligand. The intra-assay and interassay Changes in body weight, urine volume, UOsm, and SNa
levels in the experimental SIADH rats and the dDAVP-coefficients of variation were less than 10%. The serial
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rats; a decrease in urine volume and an increase in UOsm
were more manifest than those found in the experimental
SIADH rats. This may be compensated, in part, by the
reduced water intake. Also, SNa levels remained normal
in the control rats fed either liquid diet or pelleted chow
diet.
[3H]AVP binding to the membranes of renal medulla
was examined. Scatchard analysis showed a single class
of receptors (data not shown). In the control rats, Kd
was 0.23  10	11 mol/L, and Bmax was 11.8 pmol/L/mg
protein. After the start of infusion of dDAVP and the
intake of liquid diet in the experimental SIADH rats,
Bmax promptly decreased to the nadir of 3.9 pmol/L/mg
protein on day 2 and thereafter suppressed at approxi-
mately 60% of the control rats (Fig. 1). There was no
alteration in Kd values during the seven-day observation
period in the SIADH rats. In the dDAVP-excess rats,
Bmax was decreased from 11.2 to 5.8 pmol/L/mg proteins
on day 2, followed by a slight decrease to 5.2 pmol/L/mg
protein on day 7. Also, there was no difference in Kd
values during the observation period in the dDAVP-
excess rats. There was no significant difference in Bmax
between the experimental SIADH rats and the dDAVP-
excess rats on days 2 and 7. The nonspecific binding
component of [3H]AVP receptor binding represented
approximately 55% of the total binding.
Figure 2 shows the densitometric analysis of AVP V2
receptor mRNA expression, analyzed by RT-PCR, in
both the SIADH rats and the dDAVP-excess rats. RT-
PCR was analyzed from four rats at all time points. In
both groups of rats, the expression of AVP V2 receptor
mRNA was decreased in parallel with the reduction in
its receptor capacity (Bmax). The nadir of the expression
was found at 12 hours after the start of experiment in
the SIADH rats and on day 7 in the dDAVP-excess rats.
The expression was somewhat recovered on day 2 andFig. 3 (Continued). (C ) Densitometric analysis of AQP-2 mRNA ex-
thereafter in the SIADH rats.pression in the kidney of the experimental SIADH rats () and the
dDAVP-excess rats (). *P  0.05 and **P  0.01 vs. the control. Figure 3 shows the expression of AQP-2 mRNA in
†P  0.05 vs. the dDAVP-excess rats. Values are means  SEM, N 
 4. kidneys of the rats with experimental SIADH and dDAVP
excess. There was a major transcript at 1.5 kb, which
represents AQP-2 mRNA; 4.4 kb also was detected, that
is, alternative splicing or polyadenylation variants, asexcess rats are shown in Table 1. In the experimental
SIADH rats, serum Na levels decreased to below 120 described previously [15, 29]. As shown in Figure 3A,
the expression of AQP-2 mRNA was promptly increasedmmol/L on day 2, and hyponatremia remained less than
120 mmol/L throughout the rest of the observation pe- after the start of dDAVP infusion in the experimental
SIADH rats. Densitometric analysis of AQP-2 mRNAriod. The SIADH rats failed to concentrate urine maxi-
mally. UOsm relatively increased to 1706.5 307.1 mmol/kg expression in Northern blotting is shown in Figure 3C,
and its expression reached a maximal level of 182.6 on day 2, followed by the prompt decline to approxi-
mately 800 mmol/kg thereafter. This alteration was re- 13.6% on day 2, followed by a gradual decline to 153.5 
29.8% on day 7. The expression of AQP-2 mRNA wasflected by an increase in body fluid because the rats
were fed a liquid diet. However, the dDAVP-excess rats therefore up-regulated throughout the seven-day ob-
servation period in the experimental SIADH rats. Theshowed a distinctly different water balance from that of
the experimental SIADH rats. There was no change in SNa AQP-2 mRNA expression in the dDAVP-excess rats
is shown in Figure 3B. This expression progressivelylevels during the seven-day observation period. Urinary
concentrating ability persisted in the dDAVP-excess increased for up to 323.7  23.8% on day 7, without any
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Fig. 4. Western blot analysis of AQP-2 protein
in renal medulla of the experimental SIADH
rats (A) and the dDAVP-excess rats (B) dur-
ing the seven-day observation period.
reduction. This was verified by the densitometric analysis through day 7. In the control rats urinary excretion of
that the expression of AQP-2 mRNA was significantly AQP-2 remained low during the observation period.
greater in the dDAVP-excess rats than that in the experi- Tissue cAMP levels were determined in both the
mental SIADH rats on days 2 and 7 (day 2: 297.7  22.3 SIADH rats and the dDAVP-excess rats. Basal cAMP
vs. 182.6  13.6%, N 
 4, P  0.05 day 7: 323.7  23.8% levels in renal medullary tissues are shown in Table 2.
vs. 153.5  29.8%, N 
 4, P  0.05). There was no difference in cAMP levels between the
Figure 4 shows AQP-2 protein in renal medulla of two groups of rats. In addition, the exposure to 1 
the rats with experimental SIADH and dDAVP-excess. 10	7 mol/L AVP did not cause a significant increase in
Immunoblots showed bands at 29 and 36 to 45 kD, indi- cAMP levels in both groups of rats (day 2, 156.1 21.4 vs.
cating AQP-2 protein. The high-molecular-weight mass 188.5 26.1; day 7, 121.7 23.1 vs. 116.1 19.8 fmol/g
bands of 36 to 45 kD were the glycosylated form of protein, N 
 4, P 
 NS). In contrast, cAMP levels were
AQP-2 protein [15, 29]. Basically, the results are quite increased by 1  10	7 mol/L AVP from 73.3  19.1
similar to those of AQP-2 mRNA expression. AQP-2 to 204.5  22.4 fmol/g protein in the homogenates of
protein expression was increased after the infusion of medullary tissues from the control rats (N
 4, P 0.01).
dDAVP in the experimental SIADH rats (Fig. 4A). The
maximal expression was found on day 2, which was
220.6  18.2% over the basal level by the densitometric DISCUSSION
analysis (N 
 4, P  0.05; Fig. 4C). After day 2, AQP-2 The present study examined the antidiuretic response
expression seemed to decline throughout the rest of ob- observed in chronic AVP excess, in the presence or ab-
servation period, but it remained significantly high over sence of volume expansion. Two contrasting animal
the basal level (P 0.05). An increase in AQP-2 protein models were created by giving the liquid diet or not in
was also evident in the dDAVP-excess rats (Fig. 4B). It rats. Both groups received subcutaneous administration
was greater in the dDAVP-excess rats than that in the of dDAVP at 5 ng/h. The dDAVP-excess rats maintained
experimental SIADH rats on days 2 and 7 (day 2: 290.4
the maximally concentrated urine, as UOsm increased to25.6% vs. 220.6  18.2%, P 
 NS; day 7: 302.9  28.1%
approximately 3000 mmol/kg during the observation pe-vs. 199.3  13.1%, P  0.05, N 
 4).
riod. There was marked impairment in urinary concen-Figure 5 shows urinary excretion of AQP-2 in three
trating ability in the experimental SIADH rats, since thisgroups of rats: experimental SIADH rats, dDAVP excess
UOsm kept to approximately 800 to 900 mmol/kg in therats, and control rats that were given 0.15 mol/L NaCl
sustained phase. This water balance study confirmed pre-by the osmotic minipump and liquid diet. Urinary ex-
vious observations by Verbalis and Drutarosky and ourcretion of AQP-2 promptly increased after starting the
group [5, 36]. The up-regulation of AQP-2 mRNA ex-infusion of dDAVP in the experimental SIADH rats
pression was found in two groups of the experimentaland in the dDAVP-excess rats. It reached the maximal
SIADH rats and the dDAVP-excess rats during the ob-level of 2259.2  471.0 fmol/mg creatinine on day 5 in
servation period. The expression of AQP-2 mRNA wasthe dDAVP-excess rats. However, urinary excretion of
significantly less in the experimental SIADH rats thanAQP-2 reached a plateau on day 1 and then maintained
in the dDAVP-excess rats, as shown by the densitometricthat level throughout the observation period in the ex-
analysis. Similar results were obtained with the AQP-2perimental SIADH rats. Urinary excretion of AQP-2
protein expression in the two groups of rats. Therefore,was approximately one third less in the experimental
SIADH rats than that in the dDAVP-excess rats on day 3 it seems likely that these alterations in AQP-2 mRNA
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with chronic AVP excess [40]. Additionally, there was a
significant difference in urinary excretion of AQP-2 be-
tween the experimental groups, SIADH rats and the
dDAVP-excess rats. Thus, the attenuation of the increases
in AQP-2 mRNA and protein expression in the experi-
mental SIADH rats was again supported by the level of
urinary excretion of AQP-2 in comparison to the dDAVP-
excess rats, where the same amount of dDAVP was in-
fused continuously. As urinary excretion of AQP-2 ac-
counts for the cellular action of AVP in collecting duct
cells, the antidiuretic action of AVP is apparently im-
paired in the experimental SIADH rats, yielding a lower
AVP response than anticipated from the infused
dDAVP levels.
We simultaneously determined AVP V2 receptor func-
tion in kidneys of the experimental SIADH rats and the
dDAVP-excess rats. In contrast to the up-regulation of
AQP-2 mRNA expression, the AVP V2 receptor func-
tion was down-regulated in chronic AVP excess states.
Bmax in kidneys of the experimental SIADH rats promptly
decreased to the nadir of 3.9 pmol/L/mg protein on day
2 and suppressed to approximately 60% of the level in
control rats thereafter. The down-regulation of AVP V2
receptor function also was found in the dDAVP-excess
rats during the seven-day observation period. Therefore,
this alteration in the AVP V2 receptor function was not
different between these two groups of rats. In addition,
the down-regulation of AVP V2 receptor mRNA expres-
sion was shown in both groups of rats. These observa-
tions indicate that there is a marked dissociation in the
regulation between AVP V2 receptor function and AQP-2
gene expression. It is clear that the down-regulation of
AVP V2 receptor function plays a role in the antidiuretic
action of AVP to an appropriate extent. In contrast, Tian
et al showed that dDAVP treatment reduced AVP V2
receptor binding to 72% of normal values [11]. WaterFig. 4 (Continued). (C ) Densitometric analysis of AQP-2 protein ex-
loading induced a further marked down-regulation ofpression in the kidney of the experimental SIADH rats () and the
dDAVP-excess rats (). *P  0.05 and **P 0.01 vs. the control. †P  AVP V2 receptor binding during its escape from AVP-
0.05 vs. the dDAVP-excess rats. Values are means  SEM, N 
 4. induced antidiuresis. The authors suggested that an AVP-
independent mechanism of down-regulation of AVP V2
receptor function might be involved in the initiation of
physiological renal escape from AVP. The down-regula-and protein expression lead to the associated impairment
in urinary concentrating ability. tion of AVP V2 receptor was evident in a chronic AVP
excess state, as shown by Tian et al’s work [11] as well asIt is evident that AQP-2 is partly excreted into urine,
which comprises approximately 3% of the AQP-2 in the our current studies. However, there are significant differ-
ences in the results of the receptor experiments derivedcollecting duct cells [43–45]. In normal subjects, urinary
excretion of AQP-2 varies over a wide range in various from these two studies. The potential reasons for these
differences may be the present lower specific activity ofphysiological conditions. These variations correlate with
comparable changes in plasma AVP levels [46]. Urinary [3H]AVP with a consequential difference in the signal-
to-noise ratio, and higher Bmax values, found in our studyexcretion of AQP-2 was significantly greater in both ex-
perimental groups, SIADH rats and dDAVP-excess rats, in contrast to the previous study using 125I-AVP.
The present study demonstrates the marked differencethan in the control group. The enhanced urinary excre-
tion of AQP-2 was tightly linked to the up-regulation of in urinary concentrating ability and body fluid homeosta-
sis between the two models, the experimental SIADHAQP-2 mRNA, and protein expression in the kidneys
in these pathological states of water retention, associated rats and the dDAVP-excess rats. The difference was
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Table 2. Basal cAMP levels in renal medullary tissues of the
experimental SIADH rats and the dDAVP-excess rats
Intracellular cAMP fmol/lg protein
3 Hours Day 2 Day 7
Control rats/liquid diet 73.219.4 88.710.8 72.98.6
SIADH rats 105.223.1 103.527.6 86.78.5
dDAVP-excess rats 86.035.8 146.926.3 66.512.0
Abbreviations are: cAMP, cyclic adenosine monophosphate; SIADH, syn-
drome of inappropriate secretion of antidiuretic hormone; dDAVP, 1-damino-
8-d-arginine vasopressin. Values are means  SEM, N 
 4.
lemic state. In a chronic AVP excess state, adaptation
of AQP-2 gene regulation participates in the homeostasis
of water balance. Under these conditions, further hydra-
Fig. 5. Urinary excretion of AQP-2 (UAQP-2) in three groups of the
tion should be avoided. The present results strongly sup-experimental SIADH rats (), the dDAVP-excess rats (), and the
control rats, which were given 0.15 mol/L NaCl by osmotic minipump port the previous study of Ecelbarger et al [9]. It was
and a liquid diet (). *P  0.01 vs. the control. †P  0.05 vs. the reported that in the rats receiving dDAVP, water loading
dDAVP-excess rats. Values are means  SEM, N 
 6.
via a liquid diet suppressed the increased expression of
AQP-2 mRNA and protein, but not AQP-1, -3 or -4, when
compared with their controls that were continuously of-
fered pelleted chow. Their model was somewhat differ-clearly noted in the experimental SIADH rats, which had
ent from that used in the present study. Specifically, aftertwofold greater urine volume, reduced UOsm and severe
four days of dDAVP administration and pelleted chow,hyponatremia in comparison with the dDAVP-excess
the experimental SIADH rats, which continuously re-rats. Circulatory blood volume was not measured directly,
ceived dDAVP, were offered a liquid diet instead ofbut hypervolemia was certain. In our previous report,
pelleted chow. Their control rats continued to receiveadministration of the non-peptide V2 receptor antago-
ad libitum water and pelleted chow [9]. They furthernist, OPC-31260, markedly increased urine volume and
suggested that the basis of the blunted signaling of AVPnormalized serum sodium in the SIADH rats [36]. There-
in renal collecting duct cells could be the decreased intra-fore, it seemed likely that the animals had dilutional hy-
cellular cAMP levels [10]. However, this conclusion wasponatremia. In contrast, the dDAVP-excess rats had
not supported by our study, since there was no differenceconcentrated urine and probably maintained normal cir-
in cAMP levels between the experimental SIADH ratsculatory blood volume during the seven-day observation
and the dDAVP-excess rats. These varying results mayperiod, since they maintained a normal level of serum
arise from different experimental methods. Those au-sodium. The “AVP escape” phenomenon from anti-
thors specifically used the inner medullary tissues fordiuresis is described in classic physiology [5–8]. The pres-
cAMP measurement, while the outer and inner medul-ent study sought cellular and molecular approaches to
lary tissues were employed in our studies. Also, cAMPdescribe the adaptation of urinary concentration in the
production was stimulated by dDAVP [10] and by AVPexperimental SIADH rats. There were two reciprocal
in our studies. The down-regulation of AVP V2 receptorsalterations in renal collecting duct cells: the prompt re-
in the state of continuous administration of dDAVP isduction in AVP V2 receptor capacity and mRNA expres-
understandable, but what mechanisms operate in thesion, and the up-regulation of AQP-2 mRNA and protein
expression. The preliminary finding of the AQP-2 mRNA expression of AQP-2 mRNA? As mentioned earlier,
the experimental SIADH rats had hypervolemia andexpression previously was shown in another study from
our laboratories [29]. The down-regulation of AVP V2 hyponatremia. This volume state seems likely to be a
critical difference. A similar susceptibility was noted byreceptor was comparable in the two experimental rat
groups, but the up-regulation of the AQP-2 gene was Murase et al [12], who used a similar model of rat to the
one studied by Ecelbarger et al [9, 10]. In their study,significantly less in the experimental SIADH rats than
that in the dDAVP-excess rats. Specifically, the experi- neither systemic nor interstitial osmolality appears to
correlate appreciably during escape from antidiuresismental SIADH rats showed an AVP-independent change
in AQP-2 gene expression, thus, resulting gene expres- [12], suggesting that AVP- and osmolality-independent
factors related to extracellular fluid volume expansionsion of AQP-2 was lower than anticipated in response
to administered dDAVP. This attenuated regulation of may regulate kidney AQP-2 expression. Matsumura et
al reported that a cAMP-responsive element resides inAQP-2 gene led to a decrease in urinary concentrating
ability in the experimental SIADH rats in a hypervo- the 5-flanking region of the AQP-2 gene [27]. It could
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porins in escape from vasopressin-induced antidiuresis in rat. J Clinbe interpreted that either hypervolemia or hypotonicity
Invest 99:1852–1863, 1997
attenuates the postreceptor signaling of AVP, particu- 10. Ecelbarger CA, Chou CL, Lee AJ, et al: Escape from vasopressin-
induced antidiuresis: Role of vasopressin resistance of the collect-larly the transcriptional regulation of AQP-2 gene ex-
ing duct. Am J Physiol 274:F1161–F1166, 1998pression, in renal collecting duct cells. If this is so, then
11. Tian Y, Sandberg K, Murase T, et al: Vasopressin V2 receptorcirculating blood volume could play a crucial role in the binding is down-regulated during renal escape from vasopressin-
induced antidiuresis. Endocrinology 141:307–314, 2000cellular action of AVP in renal collecting duct cells, as
12. Murase T, Ecelbarger CA, Baker EA, et al: Kidney aquaporin-2well as in the release of AVP from neurohypophysis
expression during escape from antidiuresis is not related to plasma
[47, 48]. Further studies are necessary to elucidate the or tissue osmolality. J Am Soc Nephrol 10:2067–2075, 1999
13. Ishikawa S: Cellular action of arginine vasopressin in the kidney.exact mechanism.
Endocr J 40:373–386, 1993In conclusion, we demonstrate that the experimen-
14. Knepper MA, Rector FC Jr.: Urinary concentration and dilution,
tal SIADH rats suffering from hypervolemia and associ- in The Kidney, edited by Brenner BM, Rector FC Jr., Philadel-
phia, Saunders, 1995, pp 532–570ated dilutional hyponatremia showed marked attenua-
15. Fushimi K, Uchida S, Hara Y, et al: Cloning and expression oftion of urinary concentrating ability in comparison to
apical membrane water channel of rat kidney collecting tubule.
the dDAVP-excess rats. The prompt reduction in AVP Nature 361:549–552, 1993
16. Sasaki S, Fushimi K, Saito H, et al: Cloning, characterization andV2 receptor binding capacity and mRNA expression was
chromosomal mapping of human aquaporin of collecting duct.comparable between the two models of rats, but the up- J Clin Invest 93:1250–1256, 1994
regulation of AQP-2 mRNA and protein expression was 17. Hayashi M, Sasaki S, Tsuganezawa H, et al: Expression and
distribution of aquaporin of collecting duct are regulated by vaso-significantly diminished in the experimental SIADH rats.
pressin V2 receptor in rat kidney. J Clin Invest 94:1778–1783, 1994The present results indicate that in SIADH under a 18. Nielsen S, DiGiovanni SR, Christensen EI, et al: Cellular and
chronic AVP excess state, either hypervolemia or hypo- subcellular immunolocalization of vasopressin-regulated water chan-
nel in rat kidney. Proc Natl Acad Sci USA 90:11663–11667, 1993tonicity may attenuate the post-receptor signaling of AVP
19. Nielsen S, Chou CL, Marples D, et al: Vasopressin increases water
in renal collecting duct cells. permeability of kidney collecting duct by inducing translocation of
aquaporin-CD water channels to plasma membrane. Proc Natl
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